QuidelOrtho (QuidelOrtho) Insider Ownership : 7.10 % (As of May. 15, 2024)

View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, QuidelOrtho's insider ownership is 7.10%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, QuidelOrtho's Institutional Ownership is 84.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, QuidelOrtho's Float Percentage Of Total Shares Outstanding is 68.08%.

QuidelOrtho Insider Ownership Historical Data

The historical data trend for QuidelOrtho's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Insider Ownership Chart

QuidelOrtho Historical Data

The historical data trend for QuidelOrtho can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	7.02	7.02	7.02	7.02	7.03	7.03	7.03	7.07	7.08	7.10

QuidelOrtho Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

QuidelOrtho (QuidelOrtho) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

QL1A:Germany

Address

9975 Summers Ridge Road, San Diego, CA, USA, 92121

Website

https://www.quidelortho.com

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Executives

Louise Brandy	officer: SVP, Chief Information Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein	officer: Chief Administrative Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith	director	125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael	director	618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy	officer: SVP, Cardio/Metabolic Unit	9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll	officer: SVP, Research and Development	12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler	director
Robert R. Schmidt	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli	officer: SVP, Molecular Bus. Unit	9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski	officer: See Remarks	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr.	director	82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges	officer: SVP, General Counsel	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant	director, officer: Chairman & CEO	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky	officer: Chief Financial Officer	1717 DEERFIELD ROAD, DEERFIELD IL 60015